Fermenta Biotech

Fermenta Biotech Retained Earnings

The Retained Earnings of Fermenta Biotech (506414.BO) as of Oct 19, 2026 is 3.50 B INR. In the previous year, Retained Earnings was 2.63 B INR — a change of 33.18% (higher).

Retained Earnings

3.50 BINR

YoY

33.18%

Last updated:

Retained Earnings of Fermenta Biotech is 2025 3.50 B INR. Retained Earnings of Fermenta Biotech was 2024 2.63 B INR. It decreases by 33.18% higher compared to the previous year.

The Fermenta Biotech Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2018
1.22 B INR
Jan 1, 2019
2.45 B INR
Jan 1, 2020
2.89 B INR
Jan 1, 2021
3.34 B INR
Jan 1, 2022
3.42 B INR
Jan 1, 2023
2.88 B INR
Jan 1, 2024
2.63 B INR
Jan 1, 2025
3.50 B INR
The Fermenta Biotech Retained Earnings history
YEARRetained EarningsYoY
3.50 BINR+33.18%
2.63 BINR-8.68%
2.88 BINR-15.92%
3.42 BINR+2.39%
3.34 BINR+15.75%
2.89 BINR+17.83%
2.45 BINR+100.64%
1.22 BINR+5.74%
1.16 BINR+9.58%
1.05 BINR-1.70%
1.07 BINR-0.95%
1.08 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Fermenta Biotech Stock analysis

What does Fermenta Biotech do? Fermenta Biotech Ltd is a pharmaceutical company headquartered in Thane, India, listed on the stock exchange on 4 January 1990. With a workforce of 550 employees, the firm operates primarily in the manufacturing and supply of Vitamin D3 and other bulk drugs. Its Chemicals and Bulk Drug segment produces enzymes and specialized technologies for the biopharmaceutical life cycle, serving industries such as pharmaceuticals, animal feed, and food fortification. Additionally, the company offers nutritional ingredients like fish oil-derived cholesterol and natural astaxanthin. The Property segment complements these operations by managing the renting and sale of real estate assets. Fermenta Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fermenta Biotech stock

Retained Earnings of Fermenta Biotech is 3.50 B INR in 2025.

Retained Earnings of Fermenta Biotech changed from 2.63 B INR to 3.50 B INR, representing a 33.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings Fermenta Biotech since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's Fermenta Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Fermenta Biotech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Fermenta Biotech